The role of ECMO in the treatment of patients with severe COVID-19 (Acute Respiratory Distress Syndrome (ARDS) and/or acute refractory heart failure) is not yet known. The present study will aim to report the results of the ECMO management of the most severe forms of COVID-19 through the first French ECMO registry.
The main objective of this study is to evaluate the hospital survival of COVID-19 patients
supported by venovenous or venoarterial ECMO in a multicenter registry.
The secondary objectives are to describe the characteristics of COVID-19 patients who have
received ECMO support, to identify the risk factors associated with hospital mortality, to
analyze the outcomes after ECMO weaning including survival at day 28 and day 90, and to
analyze the utility of a circulatory support mobile unit in a severe pandemic
Inclusions are both prospective and retrospective in order to collect data over the whole
pandemic
Inclusion Criteria:
- All COVID-19 patients, adults or children,
- Tested positive by RT-PCR for SARS-CoV2 (nasopharyngeal swabs, sputum, endotracheal
aspiration, bronchoalveolar lavage or stool sample) and / or with a diagnosis made on
chest CT findings,
- Supported by venovenous or venoarterial ECMO
Exclusion Criteria:
- Temporary legally protected Adults over a set period or waiting for protection
supervision, guardianship
- Patients or proxies who express their opposition to study participation
Angers University Hospital
Angers, France
Besançon Hospital
Besançon, France
Brest university Hospital
Brest, France
Caen University Hospital
Caen, France
Clermont ferrand University hospital
Clermont-Ferrand, France
APHP Henri Mondor Paris University Hospital
Créteil, France
Dijon University Hospital
Dijon, France
Vendée Hospital
La Roche-sur-Yon, France
Grenoble University Hospital
La Tronche, France
APHP Kremli Bicetre Paris University Hospital
Le Kremlin-Bicêtre, France
Marie Lannelongue Hospital
Le Plessis-Robinson, France
Lens Hospital
Lens, France
Lille University Hospital
Lille, France
Limoges University Hospital
Limoges, France
Clinique de la Sauvegarde
Lyon, France
Lyon University Hospital
Lyon, France
Marseille Européen Hospital
Marseille, France
APHM la Timone- Marseille University Hospital
Marseille, France
Clairval Hospital
Marseille, France
Metz University Hospital
Metz, France
Montpellier University Hospital
Montpellier, France
Emile Muller Hospital
Mulhouse, France
Nancy University Hospital
Nancy, France
Nantes University Hospital
Nantes, France
Ambroise Paré Hospital
Neuilly-sur-Seine, France
Nimes University Hospital
Nimes, France
Institut Mutualiste Montsouris
Paris, France
APHP Hopital Européen Georges Pompidou - Paris University Hospital
Paris, France
APHP necker Paris University Hospital
Paris, France
APHP Bichat - Paris University Hospital
Paris, France
APHP La Pitié Salpêtrière Paris University Hospital
Paris, France
Bordeaux University Hospital
Pessac, France
Poitiers University hospital
Poitiers, France
Reims University hospital
Reims, France
Rennes University hospital
Rennes, France
Rouen University Hospital
Rouen, France
Saint brieuc Hospital
Saint brieuc, France
La Réunion University Hospital
Saint-Denis, France
Saint Nazaire Hospital
Saint-Nazaire, France
Saint Etienne University Hospital
Saint-Étienne, France
Strasbourg University Hospital
Strasbourg, France
Toulouse University Hospital - Rangueil Hospital
Toulouse, France
Tours University Hospital
Tours, France
Bretagne Atlantique Hospital
Vannes, France
Cécile Ferragu
0299282555
cecile.ferragu@chu-rennes.fr
DRI
0299282555
dri@chu-rennes.fr